about
Designing a broad-spectrum integrative approach for cancer prevention and treatment.Gene Electrotransfer of Plasmid-Encoding IL-12 Recruits the M1 Macrophages and Antigen-Presenting Cells Inducing the Eradication of Aggressive B16F10 Murine Melanoma.Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphomaThe AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studiesEvaluation of antigen specific recognition and cell mediated cytotoxicity by a modified lysispot assay in a rat colon carcinoma modelNovel insights into Notum and glypicans regulation in colorectal cancerStrategies for effective naked-DNA vaccination against infectious diseases.The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation.Recent advances in epitope design for immunotherapy of cancer.DNA vaccination strategies for anti-tumour effective gene therapy protocols.BCR/ABL1 fusion transcripts generated from alternative splicing: implications for future targeted therapies in Ph+ leukaemias.Electroporation in DNA vaccination protocols against cancer.Gene therapy: the role of cytoskeleton in gene transfer studies based on biology and mathematics.Immune evasion in cancer: Mechanistic basis and therapeutic strategies.Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransferIncreased spermine oxidase (SMO) activity as a novel differentiation marker of myogenic C2C12 cells.A somatic mutation in the 5'UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency.Intramuscular DNA vaccination protocols mediated by electric fields.Immune response at birth, long-term immune memory and 2 years follow-up after in-utero anti-HBV DNA immunization.The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation.The Fourteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-14), September 24-26, 2014, Rome, Italy: rethinking anti-tumor vaccines in a new era of cancer immunotherapy.Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer.Tissue damage modeling in gene electrotransfer: the role of pH.ApoE gene delivery inhibits severe hypercholesterolemia in newborn ApoE-KO mice.Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: transgene expression, immunity and safety.Simple and effective determination of apolipoprotein E genotypes by positive/negative polymerase chain reaction products.Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infectionGenomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinomaIn Vivo Evaluation of a New Recombinant Hyaluronidase to Improve Gene Electro-Transfer Protocols for DNA-Based Drug Delivery against CancerA combined analytical approach reveals novelEXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patientsElectroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administrationMycobacterium smegmatis Expressing a Chimeric Protein MPT64-Proteolipid Protein (PLP) 139–151 Reorganizes the PLP-Specific T Cell Repertoire Favoring a CD8-Mediated Response and Induces a Relapsing Experimental Autoimmune EncephalomyelitisAlternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approachesAnti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma modelHyaluronidase contributes to early inflammatory events induced by electrotransfer in mouse skeletal muscleCurrent understanding and clinical utility of miRNAs regulation of colon cancer stem cellsA Novel 3D Scaffold for Cell Growth to Asses Electroporation EfficacyThe Efficiency of Gene Electrotransfer in Breast-Cancer Cell Lines Cultured on a Novel Collagen-Free 3D Scaffold
P50
Q30736359-73332D5F-9279-415A-B9B9-42FF71BF663BQ33741348-8832D86A-9D0D-4ACD-9F30-FE465839D845Q33814247-B09DBEC4-553D-4DB7-8980-B03B9965EC71Q34772160-BE5706AB-BE16-4982-BE7C-1B7A10E3D791Q36092291-467AEE88-B7B1-4FC8-A664-9E05FC6860B1Q36562344-959DE2E0-1C5B-4070-BF8B-A592E87EE297Q37232680-FA89EC57-7664-4945-93B8-CEF9B71FF518Q37237119-0B9E3105-988F-4BCC-89BE-2D4E627925A8Q37517629-46FF9D9B-435D-4191-A372-875355D2D138Q37730620-A1A5CAEF-9062-473B-AEBE-14F93396FD8FQ37980866-4BF5C274-6B8E-49F1-BE16-3B49DB9BB6B9Q38056956-C24E6CE9-0554-435C-881A-A3AE58A3D798Q38194191-9EA86CD4-D2A5-431A-AFE5-6F0B4C659D6AQ38394302-9124B1C6-5E15-4C89-9CF9-058D960648C8Q38525545-AE09625D-F005-4A5F-B6EF-8E2A1D0F05FEQ39929848-2A37D6F1-ACBB-4281-B34D-D8F2D67B245EQ40787469-6A04BAE2-E7BC-4EDE-8D2F-25E09F5FA295Q42229188-0B0C9B4A-7021-426E-B9BF-ECB85A488E57Q45873428-17D4EC01-91C9-4930-BCE2-1B19C411930BQ46592009-3D0A61D1-9A2F-4ED5-8372-A5ADFAACB9C0Q49144515-4C934813-C317-4CCB-8A4D-C2F13275B1ACQ50232638-E12AD256-9280-4066-A4F1-C75ED8EC8682Q51079607-26DE54C1-61E2-4769-8E8A-AE080CB08419Q51979757-1525DC49-83DF-4B0C-84D8-DA62CDF6C27BQ51988941-71B76322-35D9-40A2-BA07-4A5DD9D24033Q54585946-5476824B-F911-4695-8E10-F30B505C9953Q57665233-FB2B1BD7-81F2-4849-B793-B6993CF73C92Q57748300-68D01E04-F496-45DC-8E45-A4AF8B73546DQ58108216-82078FCB-321B-4F94-8C80-28BB32497DC7Q58193453-307A696C-5F6E-49DC-91BF-CFC244961510Q61819398-47477877-E897-4A88-9B7C-7FDDD11043A6Q64133889-1A1DA6CC-BC1D-41F9-8022-3D098958921BQ80422092-83A0EC80-25B9-43DE-A309-8AB59B595E51Q80949000-83401DF0-E6E4-49BE-8004-21B835420658Q86003833-716D37AF-74EC-4D82-BB76-312341561DA0Q91064433-DDBC6E13-3CB9-4E80-984A-9CE8FC87E4F9Q91378682-49FCCCF1-294E-446D-8BC8-40151A4652C1Q93264063-FD2A95CB-00B3-4B35-A1FA-643EE45E0B2C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Emanuela Signori
@ast
Emanuela Signori
@en
Emanuela Signori
@es
Emanuela Signori
@nl
type
label
Emanuela Signori
@ast
Emanuela Signori
@en
Emanuela Signori
@es
Emanuela Signori
@nl
prefLabel
Emanuela Signori
@ast
Emanuela Signori
@en
Emanuela Signori
@es
Emanuela Signori
@nl
P106
P1153
55996590200
P31
P496
0000-0003-0286-7401